Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120108) titled 'Blended Implementation Strategies to Reduce HPV Vaccine Delay and Increase Vaccine Uptake' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Nanjing Medical University
Condition:
Cervical cancer
Intervention:
Usual Care Group:Participants in the usual care group will receive standard immunization services, which include a letter to parents distributed by the Center for Dise
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Usual Care Group:480;Intervention Group:480;
Countries of Recruitment:
China
To know more, ...